首页|小檗碱介导钟控基因调节糖脂代谢改善肝细胞胰岛素抵抗的分子机制

小檗碱介导钟控基因调节糖脂代谢改善肝细胞胰岛素抵抗的分子机制

扫码查看
探讨小檗碱介导脑和肌肉芳香烃受体核转运样蛋白1基因(brain and muscle arnt-like 1,BMAL1)为中心的钟控基因调节代谢网络改善肝细胞胰岛素抵抗(insulin resistance,IR)的分子机制.优化建立地塞米松诱导肝IR-HepG2模型,5、10、20μmol·L-1小檗碱干预24 h.葡萄糖氧化酶法和细胞活力(cell counting kit-8,CCK-8)法分别检测细胞葡萄糖消耗量和细胞活力;过碘酸-雪夫(periodic acid-Schiff stain,PAS)染色法和脂质荧光法分别检测糖原和脂质;免疫荧光检测BMAL1和昼夜自发输出周期蛋白kaput(circadian locomotor output cycles kaput,CLOCK);蛋白免疫印迹法检测BMAL1、CLOCK、昼夜节律调节因子2(period circadian clock 2,PER2)、隐花色素昼夜节律调节因子1(cryptochrome circadian regulator 1,CRY1)、Rev-Erbα、碳水化合物应答元件结合蛋白(carbohydrate response element-binding protein,ChREBP)、过氧化物酶体增殖物激活受体 α/γ(peroxi-some proliferators-activated receptorsα/γ,PPARα/γ)、固醇调节元件结合蛋白1C(sterol regulatory element-binding protein 1C,SREBP-1C)、哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)、蛋白激酶B(protein kinase B,Akt)、糖原合成酶激酶-3β(glycogen synthase kinase-3β,GSK3β)、乙酰辅酶A羧化酶1(acetyl coenzyme A carboxylase 1,ACC1)、脂肪酸合成酶(fat-ty acid synthase,FASN)、肉碱棕榈酰转移酶1α(carnitine palmitoyltransferase 1α,CPT1α)、烟酰胺磷酸核糖转移酶(nicotinamide phosphoribosyltransferase,NAMPT)、沉默信息调节因子1(silent information regulator 1,SIRT1)、脂联素(adiponectin,ADPN)、胰岛素受体底物2(insulin receptor substrate 2,IRS2)、磷脂酰肌醇3-激酶p85调控亚基(phosphatidylinositol 3-kinase regulatory sub-unit p85,PI3Kp85).此外,检测cAMP依赖蛋白激酶α(adenosine monophosphate-activated protein kinase,AMPKα)、Akt、mTOR、GSK3β 和BMAL1磷酸化水平.添加20μmol·L-1 CLK8抑制剂检测葡萄糖消耗量及mTOR、ChREBP和PPARα 蛋白.结果显示,小檗碱可增加IR-HepG2细胞葡萄糖消耗量和糖原含量且降低胞内脂质;增加IR-HepG2细胞时钟蛋白BMAL1和CLOCK表达及核定位,上调BMAL1.小檗碱可上调ADPN、IRS2、PI3Kp85、p-Akt(Ser473)/Akt、p-mTOR(Ser2448)/mTOR、PPARα和CPT1α水平,下调p-GSK3β(Ser9)/GSK3β、ChREBP、SREBP-1C、ACC1和FASN水平;CLK8反证研究提示抑制BMAL1:CLOCK相互作用可减弱小檗碱降糖效应,上调ChREBP且下调mTOR和PPARα水平.因而推测小檗碱介导BMAL1为中心的时钟调控代谢网络改善肝细胞IR.
Berberine regulates glucose and lipid metabolism via clock-controlled genes to ameliorate insulin resistance of hepatocytes
This study aims to investigate the mechanism of berberine in regulating the metabolism network via clock-controlled genes represented by brain and muscle arnt-like 1 (BMAL1) to ameliorate insulin resistance (IR) of hepatocytes in vitro.The HepG2 cell model of dexamethasone-induced IR (IR-HepG2) was established and treated with 5,10,and 20 μmol·L-1 berberine,respectively,for 24 h.The glucose oxidase method and cell counting kit-8 (CCK-8) assay were employed to measure extracellular glucose concentration and cell viability,respectively.Periodic acid-Schiff (PAS) staining and lipid fluorescence method were used to detect glycogen and lipids.The immunofluorescence (IF) assay was employed to detect the nuclear localization of BMAL1 and circadian locomotor output cycles kaput (CLOCK) in IR-HepG2 cells.Western blot was employed to determine the protein levels of BMAL1,CLOCK,period circadian clock 2 (PER2),cryptochrome circadian regulator 1 (CRY1),Rev-Erbα,carbohydrate response element-binding protein (ChREBP),peroxisome proliferator-activated receptors alpha and gamma (PPARα/γ),sterol regulatory element-binding protein 1C (SREBP-1C),mammalian target of rapamycin (mTOR),protein kinase B (Akt),glycogen synthase kinase-3β (GSK3β),acetyl coenzyme A carboxylase 1 (ACC1),fatty acid synthase (FASN),carnitine palmitoyltransferase 1α (CPT1α),nicotinamide phosphoribosyltransferase (NAMPT),silent information regulator 1 (SIRT1),adiponectin (ADPN),insulin receptor substrate 2 (IRS2),and phosphatidylinositol 3-kinase regulatory subunit p85 (PI3Kp85).In addition,the levels of phosphorylated adenosine monophosphate-activated protein kinase alpha (AMPKα),Akt,GSK3β,BMAL1,and mTOR were determined.Furthermore,20 μmol·L-1 CLK8 was added to measure the glucose consumption as well as the protein levels of ChREBP,PPARα,and mTOR in IR-HepG2 cells.The results showed that berberine increased the glucose consumption,lowered the lipid levels,increased the expression and nuclear localization of BMAL1 and CLOCK,and up-regulated the level of BMAL1 in IR-HepG2 cells.Furthermore,berberine up-regulated the levels of ADPN,IRS2,PI3Kp85,p-Akt (Ser473)/Akt,p-mTOR (Ser2448)/mTOR,PPARα,and CPT1α,and down-regulated the levels of p-GSK3β (Ser9)/GSK3β,ChREBP,SREBP-1C,ACC1,and FASN.The addition of CLK8 reduced glucose consumption in IR-HepG2 cells,up-regulated the ChREBP level,and down-regulated PPARα and mTOR levels by inhibiting the BMAL1 and CLOCK interaction.In summary,berberine regulated glucose and lipid metabolism via clock-controlled genes with BMAL1 at the core to ameliorate IR of hepatocytes.

type 2 diabetes mellitusinsulin resistancebrain and muscle arnt-like 1 (BMAL1)clock-controlled genesberberineglucose and lipid metabolism

延李科、崔灿、王颖、朱水兰、徐中华、肖汉月、刘伟华、涂珺

展开 >

江西中医药大学江西省中医病因学重点实验室&中医基础理论分化发展研究中心,江西南昌 330004

江西省中药药理重点实验室,江西南昌 330004

2型糖尿病 胰岛素抵抗 脑和肌肉芳香烃受体核转运样蛋白1基因(BMAL1) 时钟调控基因 小檗碱 糖脂代谢

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(23)